Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

384
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
384
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

246
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
246
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

519
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
519
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

314
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
314
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

488
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
488

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Hairyvein agrimony-derived nanovesicles in microneedles eradicate intracellular bacteria and reverse senescence to heal diabetic foot osteomyelitis.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Scalable Cr(III) Passivation Engineering for Effectively Suppressing Zinc Escape Toward Practical Ah-Level Aqueous Zinc-Ion Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A multi-strain biofilm consortium enhances gut microbiota resilience and restores post-antibiotic homeostasis.

World journal of microbiology & biotechnology·2026
Same author

An HOCl-activated chemiluminescent prodrug enabling self-reporting camptothecin release and imaging-guided therapy in peritoneal metastasis.

Bioorganic & medicinal chemistry·2026
Same author

IR783-enabled thioketal-bridged paclitaxel nanoprodrugs with ROS-responsive release for tumor imaging and chemotherapy.

Journal of photochemistry and photobiology. B, Biology·2026
Same author

Enhancing Exercise Performance Under Hypoxia: A Network Meta-Analysis and Animal Experimental Validation of Plant Bioactive Compounds.

Nutrients·2026

関連する実験動画

Updated: Jan 14, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

代謝物プロファイル予測のための変分ベイズマルチアウトプットガウス過程回帰とマイクロバイオームデータの利用

Qinghui Weng, Mingyi Hu, Guohao Peng

    IEEE transactions on computational biology and bioinformatics
    |January 12, 2026
    PubMed
    まとめ

    本研究では、ヒトマイクロバイオーム代謝物の正確な予測のために、変分ベイズマルチアウトプットガウス過程回帰(VBMOGPR)を導入する。この手法は、腸内マイクロバイオームの理解を深めるものである。

    科学分野:

    • 微生物学
    • バイオインフォマティクス
    キーワード:
    マイクロバイオーム代謝物ガウス過程回帰変分ベイズ法機械学習

    さらに関連する動画

    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
    09:52

    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

    Published on: January 10, 2025

    1.2K
    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
    05:01

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

    Published on: July 1, 2020

    3.7K

    関連する実験動画

    Last Updated: Jan 14, 2026

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    2.0K
    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
    09:52

    A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

    Published on: January 10, 2025

    1.2K
    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
    05:01

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

    Published on: July 1, 2020

    3.7K
  • 計算生物学
  • 背景:

    • ヒトマイクロバイオームは健康において重要な役割を果たしている。
    • 微生物代謝物の正確な予測は、ヒトの健康に対する腸内マイクロバイオームの影響を理解するために不可欠である。
    • 既存の手法は、複雑で高次元なマイクロバイオームデータに課題を抱えている。

    結論:

    • VBMOGPRは、微生物代謝物予測において重要な進歩を表す。
    • この手法は、ヒトの健康におけるマイクロバイオームの役割についての理解を深めるものである。
    • VBMOGPRは、微生物代謝物関連性を探求するための堅牢なツールを提供する。